Burden and Impact of Reactogenicity among Adults Receiving COVID-19 Vaccines in the United States and Canada: Results from a Prospective Observational Study
Article in Vaccines (January 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
The Novavax Heterologous Coronavirus Disease 2019 Booster Demonstrates Lower Reactogenicity Than Messenger RNA: A Targeted Review
Article in The Journal of Infectious Diseases (November 2023)
Effectiveness of chatbots on COVID vaccine confidence and acceptance in Thailand, Hong Kong, and Singapore
Article in npj Digital Medicine (May 2023)